Continuous infusion of pyridostigmine in the management of myasthenic crisis.
Saltis
L M
LM
Department of Internal Medicine, Akron City Hospital, OH.
Martin
B R
BR
Traeger
S M
SM
Bonfiglio
M F
MF
D000208:Acute Disease; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001682:Biological Availability; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D009157:Myasthenia Gravis / Q000188:drug therapy* / Q000503:physiopathology; D011729:Pyridostigmine Bromide / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D012129:Respiratory Function Tests; D013810:Therapeutic Equivalency
D011729:Pyridostigmine Bromide